Evidence map›Paper›PMID 33225251›Full record

ReviewBrain hemorrhages2021

COVID-19 and stroke: A review.

Xiaoming Qi, Kristin A Keith, Jason H Huang

Open access · diamondAbstract readReview
In one paragraph

Review in Brain hemorrhages, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. New Directions in Infection-Associated Ischemic Stroke.Journal of clinical neurology (Seoul, Korea) · 2024
    Review
  7. Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2023
    Article
  8. Article
  9. Article
  10. Stroke Risk Related to Coronavirus Disease-2019: What Have We Learned?Critical care nursing clinics of North America · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Case report of a fulminant non-aneurysmal convexity subarachnoid hemorrhage after COVID-19.Interdisciplinary neurosurgery : Advanced techniques and case management · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xiaoming QiDepartment of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA.
Kristin A KeithDepartment of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA.
Jason H HuangDepartment of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA.
Texas A&M Health Science Center · USBaylor Scott & White Health · US

Funding

Use of Engineered Nervous Tissue Constructs to Repair Extensive Nerve InjuryR01NS067435 · NINDS · UNIVERSITY OF ROCHESTER · PI HUANG, JASON H. · 2010 to 2014
$1.6M
NINDS NIH HHS R01 NS067435
6 · The paper itself

Abstract

COVID-19 patients have presented with a wide range of neurological disorders, among which stroke is the most devastating. We have reviewed current studies, case series, and case reports with a focus on COVID-19 patients complicated with stroke, and presented the current understanding of stroke in this patient population. As evidenced by increased D-dimer, fibrinogen, factor VIII and von Willebrand factor, SARS-CoV-2 infection induces coagulopathy, disrupts endothelial function, and promotes hypercoagulative state. Collectively, it predisposes patients to cerebrovascular events. Additionally, due to the unprecedented strain on the healthcare system, stroke care has been inevitably compromised. The underlying mechanism between COVID-19 and stroke warrants further study, so does the development of an effective therapeutic or preventive intervention.

Indexed as

ACE2, Angiotensin-converting enzyme 2aPL, AntiphospholipidaPTT, Activated partial thromboplastin timeCerebrovascular diseasesCOVID-19COVID-19, Coronavirus disease 2019CPR, C-reactive proteinCVD, Cerebrovascular diseaseDIC, Disseminated intravascular coagulationECMO, Extracorporeal membrane oxygenationICH, Intracranial hemorrhageIL-6, Interleukin-6MERS, Middle East Respiratory SyndromeNIHSS, National Institutes of Health Stroke ScalePT, Prothrombin timert-PCR, Reverse transcription polymerase chain reactionSARS-CoV-1, Severe acute respiratory syndrome coronavirus 1SARS-CoV-2SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2StrokeTNF-alpha, Tumor necrosis factor-alphavWF, Von Willebrand Factor

Identifiers

PMID33225251
PMCPMC7670261
OpenAlexW3104683136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.